SANTA BARBARA, CA--(Marketwired - March 17, 2014) - USDM Life Sciences
, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce Jay Crowley
will host a complimentary webinar titled "Six Months Until UDI Go Live - Issues in the Life Sciences Industry
." The presentation
is Thursday, March 20th at 11 a.m. PDT. Crowley is Vice President of the Unique Device Identification (UDI) Practice
at USDM Life Sciences.
The live webinar will address critical UDI issues medical device manufacturers face and what to do about them. The webinar will give participants an opportunity to hear what medical device companies need to be concerned about as they become UDI compliant. Presenter Jay Crowley also will discuss the compliance methods that have already led to successful UDI compliance. There will even be an opportunity for the audience to ask Crowley questions.
As Senior Advisor for Patient Safety in the Food and Drug Administration's Center for Devices and Radiological Health, Crowley developed the framework and authored key requirements for FDA's Unique Device Identification system. Crowley also led the team responsible for the development and implementation of UDI requirements.
At USDM Life Sciences, Crowley helps medical device manufacturers attain regulatory compliance as well as internal benefits and competitive advantage around UDI implementation.
About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. USDM Life Sciences has more than 14 years of experience supplying our clients in the life science industry with compliance services during each phase of their drug and product development cycle while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. For more information, please visit www.usdm.com.